The systematic review entitled “Complications and mortality of non-typhoidal salmonella invasive disease: a global systematic review and meta-analysis” has been just published in the Lancet Infectious…
We are pleased to announce that the Master in Vaccinology and Drug Development of the University of Siena is now open for applications (academic year 2021-2022). The…
On 6-8 December 2021 the Vacc-iNTS Consortium members have virtually attended the “International Conference on Typhoid & Other Invasive Salmonelloses” with the following oral presentations:…
Community engagement film used for community sensitisation and public engagement events prior to recruitment in each local area, for sero-epidemiology studies in Chikwawa, Malawi.
The Vacc-iNTS training of staff from African countries on serological assays has been held virtually on 5th and 6th November 2020. The theoretical course aimed at training…
Vacc-iNTS 2020 Annual Meeting The Vacc-iNTS 2020 Annual Meeting has been held on 22nd and 23rd October 2020. More than 75 participants from 13 countries…
We are pleased to announce that the Master in Vaccinology and Drug Development of the University of Siena is now open for applications (academic year 2020-2021). The…
The Vacc-iNTS project for the manufacture and clinical development of a vaccine against invasive non-typhoidal salmonellosis (iNTS) disease funded by the European Commission has started.…
Vacc-iNTS Kick-Off Meeting The Vacc-iNTS Consortium, made up of 12 partners from 8 different countries including iNTS disease-endemic countries, met in Siena (Italy) on 24-25th October…
“FIH Invasive Non-Typhoid Salmonella Trial”, Maheshi Ramasamy, Oxford Vaccine Group. For more details: https://cvnuk.co.uk/